FR2396018A1 - acetylated water soluble gluco-peptide prepn. from escherichia coli - used as antiinflammatories and immunostimulant(s) - Google Patents
acetylated water soluble gluco-peptide prepn. from escherichia coli - used as antiinflammatories and immunostimulant(s)Info
- Publication number
- FR2396018A1 FR2396018A1 FR7720318A FR7720318A FR2396018A1 FR 2396018 A1 FR2396018 A1 FR 2396018A1 FR 7720318 A FR7720318 A FR 7720318A FR 7720318 A FR7720318 A FR 7720318A FR 2396018 A1 FR2396018 A1 FR 2396018A1
- Authority
- FR
- France
- Prior art keywords
- escherichia coli
- antiinflammatories
- prepn
- immunostimulant
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Abstract
Nouveaux glycopeptides acétylés hydrosolubles extraits de corps microbiens lyses d'Escherichia Coli, caractérisés en ce qu'ils ont un poids moléculaire apparent supérieur à 1000 et inférieur ou egal à 200 000, renfermant au moins 25 % de substances à pouvoir biurétogène et au moins 30 % d'oses neutres, ne renferment pas d'acide diaminopimélique et présentent un maximum d'absorption dans l'ultraviolet à environ 210 m mu . Procédé de préparation et application à titre de médicaments de ces nouveaux glycopeptides acétylés.New water-soluble acetylated glycopeptides extracted from lysed microbial bodies of Escherichia Coli, characterized in that they have an apparent molecular weight greater than 1000 and less than or equal to 200,000, containing at least 25% of substances with biuretogenic power and at least 30 % neutral oses, do not contain diaminopimelic acid and have a maximum absorption in the ultraviolet at about 210 m mu. Process for the preparation and application as medicaments of these new acetylated glycopeptides.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7720318A FR2396018A1 (en) | 1977-07-01 | 1977-07-01 | acetylated water soluble gluco-peptide prepn. from escherichia coli - used as antiinflammatories and immunostimulant(s) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7720318A FR2396018A1 (en) | 1977-07-01 | 1977-07-01 | acetylated water soluble gluco-peptide prepn. from escherichia coli - used as antiinflammatories and immunostimulant(s) |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2396018A1 true FR2396018A1 (en) | 1979-01-26 |
FR2396018B1 FR2396018B1 (en) | 1980-03-07 |
Family
ID=9192864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7720318A Granted FR2396018A1 (en) | 1977-07-01 | 1977-07-01 | acetylated water soluble gluco-peptide prepn. from escherichia coli - used as antiinflammatories and immunostimulant(s) |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2396018A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993016190A1 (en) * | 1992-02-14 | 1993-08-19 | Laboratoires Om Sa | Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH314792A (en) * | 1952-05-21 | 1956-06-30 | Wander Ag Dr A | Process for the preparation of therapeutic irritants |
-
1977
- 1977-07-01 FR FR7720318A patent/FR2396018A1/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH314792A (en) * | 1952-05-21 | 1956-06-30 | Wander Ag Dr A | Process for the preparation of therapeutic irritants |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993016190A1 (en) * | 1992-02-14 | 1993-08-19 | Laboratoires Om Sa | Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract |
US5424287A (en) * | 1992-02-14 | 1995-06-13 | Laboratoires Om Sa | Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same |
Also Published As
Publication number | Publication date |
---|---|
FR2396018B1 (en) | 1980-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3263573D1 (en) | Pharmaceutically active phenylcarboxylic acid derivatives | |
NO863636D0 (en) | PROCEDURE FOR THE PREPARATION OF TRANSDERMAL RESORABLE PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES. | |
CA2209167A1 (en) | Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof | |
ES8201596A1 (en) | their preparation and use as medicines. | |
KR950702834A (en) | NOVEL GLUCAN PREPARATION | |
IL85746A0 (en) | Preparation of t cells and t cell membrane for use in autoimmune diseases | |
BR9206631A (en) | System with greater penetration into the skin for better topical administration of medications | |
AU2118488A (en) | Improvements in or relating to methods of treating damaged skin | |
EP0253887A1 (en) | LOW INTERFERON DOSAGE TO IMPROVE THE EFFICACY OF A VACCINE. | |
GEP20043237B (en) | Pyrazoline Derivatives, Method for Their Preparation and Compositions Containing Them for Treatment of Diseases Mediated by Cyclooxygenase-2 | |
NO862409L (en) | PREPARATION AGAINST ACN. | |
ATE178798T1 (en) | USE BEFORE SIMPLE OR CONJUGATED DEXTRAN IN THE PRODUCTION OF A MEDICATION TO PREVENT OR REDUCE THE RISK OF A BACTERIAL PATHOGENIC INFECTION | |
FR2396019A1 (en) | Acetylated water soluble gluco-peptide prepn. - from pseudomonas aeruginosa; used as antiinflammatories, antibacterials, and immunostimulant(s) | |
PH27214A (en) | N-2,3-butadienyl tri and tetraaminoalkane derivatives | |
NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
FR2570081B1 (en) | MEMBRANE POLYSACCHARIDES USEFUL IN PARTICULAR AS A MEDICAMENT AND PROCESS FOR THEIR PREPARATION | |
FR2396018A1 (en) | acetylated water soluble gluco-peptide prepn. from escherichia coli - used as antiinflammatories and immunostimulant(s) | |
TW325404B (en) | Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders. | |
FR2378855A1 (en) | NEW GLYCOPROTEINS ISOLATED FROM HAFNIA, METHOD OF PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS | |
NO933016L (en) | Procedure for the safe administration of fatty acid | |
DE69031569D1 (en) | PODOPHYL LOTOXIN PREPARATION CONTAINING TRIGLYCERIDE | |
Migasena et al. | Mebendazole, tetrachlorethylene and pyrantel pamoate in the treatment of hookworm infection | |
FR2433021A1 (en) | PYRIDOCARBAZOLES OLIGOMERS AND THEIR THERAPEUTIC APPLICATION | |
EP0207928A3 (en) | Fertilizer and method for its preparation | |
Pisarev et al. | Further studies on the antigoitrogenic action of iodoarachidonates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |